We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – News and Features

News

Study Shows that Geron’s Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack By The Human Immune System

Data indicate short courses of low-dose immunosuppression may be sufficient to prevent immune rejection of GRNOPC1.
News

Drug Commonly Used to Treat Bi-Polar Disorder Dramatically Increases Lifespan in Nematode Worms

Scientists at Buck Institute discovered that longevity was increased in the worms when the lithium turned down the activity of a gene that modulates the basic structure of chromosomes.
News

NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Pharmaceutical Company

As part of the feasibility agreement, NMT will apply its proprietary technology High Gravity Controlled Precipitation to the design of drug particles for pulmonary inhalation.
News

How Schizophrenia Develops: Major Clues Discovered

Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain.
News

Genes that Affect Reponses of MS to Copaxone

A group of Israeli scientists have recently identified genes responsible for the positive response of many multiple sclerosis patients to the drug Copaxone®.
News

Study Reveals how Stem Cells Decide to Become either Skeletal or Smooth Muscle

The study results provide insight into the development biology and suggest new ways to treat atherosclerosis and cancer.
News

Montreal Heart Institute Awarded $5 Million Grant from Genome Quebec

MHI’s research project based on a mixed academic/private partnership in pharmacogenomics has been selected for the new PRIVAC competition launched by Genome Quebec.
News

Report Urges Genomic Methods to Identify Toxic Chemicals Should be Developed

A report from National Research Council recommends development of genomic technologies for identifying toxic chemicals and understanding individual vulnerabilities.
News

Aastrom Announces Positive Interim Results from Phase I/II Study Involving use of Vascular Repair Cells in Patients with Critical Limb Ischemia

Early clinical data supporting use of Aastrom Bone Repair Cells (BRCs) in treatment of osteonecrosis of the femoral head also presented.
News

International Serious Adverse Events Consortium Launches Global Research Collaboration to Identify Genetic Markers Related to Adverse Drug Reactions

Newly formed nonprofit corporation unites industry, academia and government in first large-scale study of genetics and drug safety.
Advertisement